acebutolol and Hypophosphatemia

acebutolol has been researched along with Hypophosphatemia in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	16 (41.03)	24.3611
2020's	23 (58.97)	2.80

Authors

Authors	Studies
Schaefer, B; Wolf, M; Zoller, H	1
Bernal, L; Gutiérrez Casbas, A; Madero Velázquez, L; Muñoz Pérez, R; Orts, B; Rodríguez, A; Sempere, L	1
Boots, JMM; Quax, RAM	1
González Hidalgo, V; Morán López, JM	1
Schaefer, B; Wagner, S; Zoller, H	1
Musgrove, J; Wolf, M	1
Detlie, TE; Jahnsen, J	1
Andreucci, M; Calimeri, S; Cernaro, V; Comi, A; Coppolino, G; Cosentino, S; Donato, C; Leonardi, G; Lucia, CM; Michael, A; Nicotera, R; Provenzano, M	1
Edmonston, D; Wolf, M	1
Amarnani, R; Javaid, MK; Travis, S	1
Kiechl-Kohlendorfer, U; Mueller, T; Posod, A; Schaefer, B; Zoller, H	1
Achebe, M; Brandenburg, V; Carpenter, TO; Econs, MJ; Imel, EA; Peacock, M; Rubin, J; Thomsen, LL; Weber, T; Wolf, M; Zoller, H	1
Brandenburg, V; Heine, GH; Marx, N; Stöhr, R	1
Aczél, S; Bilz, S; Brändle, M; Frei, N; Räss, A; Schoeb, M	1
Ortez-Toro, JJ; Peteiro-Miranda, CM; Román-Gimeno, S; Sanz-Martín, B; Urdaniz-Borque, R	1
Fang, W; Garg, M; Kenny, R; McMahon, LP; Rizvi, QU	1
Böhm, M; Brandenburg, VM; D'Amelio, R; Emrich, IE; Fliser, D; Heine, GH; Kaddu-Mulindwa, D; Lizzi, F; Seiler-Mussler, S; Siegel, JD; Ukena, C; Wagenpfeil, S	1
Fisher, S; Jonker, L	1
Chui, F; Dashwood, A; Hay, K; Laher, S; Vale, C; Wong, YW	1
Kennedy, NA; Schaefer, B; Tilg, H; Tobiasch, M; Viveiros, A; Wolf, M; Zoller, H	1
Ganz, T; Goodnough, LT; Kalantar-Zadeh, K; Levine, MA; Seid, MH; Trumbo, H	1
Efe, O; García, JDC; Mount, DB; Sheridan, AM	1
Bernhardt, MB; Kirk, SE; Mahoney, DH; Powers, JM; Scheurer, ME	1
Borrelli, O; Chadokufa, S; Cococcioni, L; El-Khouly, S; Kiparissi, F; McCartney, S; Pensabene, L; Saliakellis, E	1
Khoo, PWR; McGrath, KH	1
Glodny, B; Schaefer, B; Zoller, H	1
Asaad, S; Econs, M; Klein, K; Rubin, JE	1
Adkinson, NF; Auerbach, M; Bernard, KE; Chertow, GM; Kaper, RF; Krop, JS; Macdougall, IC; Strauss, WE	1
Brandenburg, V; Heine, GH; Marx, N; Sandstede, L; Stöhr, R	1
Chertow, GM; Kaper, R; Krop, J; Macdougall, IC; Strauss, W; Wolf, M	1
Abreu Padín, C; Castro Ramos, JC; Gómez Peralta, F; Gómez Rodríguez, S	1
Detlie, TE; Finnes, E; Jahnsen, J; Jahnsen, ME; Lindstrøm, JC; Moum, B; Zoller, H	1
Barea Mendoza, JA; González Olmedo, J; Gredilla Zubiría, I; Mateo Alvarez, S	1
Coti Bertrand, P; Fierz, YC; Gonthier, A; Kenmeni, R; Lier, F; Pralong, F	1
Fuertes Martín, A; Inés Revuelta, S; Moralejo Alonso, L; Sánchez González, R; Ternavasio-de la Vega, HG	1
Bager, P; Dahlerup, JF; Hvas, CL	1
Braithwaite, V; Effenberger, M; Finkenstedt, A; Griesmacher, A; Moschen, A; Schaefer, B; Sulzbacher, I; Tilg, H; Viveiros, A; Vogel, W; Würtinger, P; Zoller, H	1
Atiqi, R; Heijboer, AC; Hesselink, DA; Hoorn, EJ; Sari, V; van Gelder, T	1
Mani, LY; Nseir, G; Pascual, M; Venetz, JP	1

Reviews

5 review(s) available for acebutolol and Hypophosphatemia

Article	Year
Iron Infusion and Induced Hypophosphatemia: The Role of Fibroblast Growth Factor-23. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2020, Volume: 24, Issue:3 Topics: Anemia, Iron-Deficiency; Drug-Related Side Effects and Adverse Reactions; Ferric Compounds; Fibroblast Growth Factor-23; Hematinics; Humans; Hypophosphatemia; Long Term Adverse Effects; Maltose	2020
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. Nature reviews. Nephrology, 2020, Volume: 16, Issue:1 Topics: Anemia, Iron-Deficiency; Bone and Bones; Calcium; Erythropoiesis; Familial Hypophosphatemic Rickets; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypophosphatemia; Inflammation; Iron; Maltose; Phosphates; Protein Processing, Post-Translational; Renal Insufficiency, Chronic; RNA, Messenger; Transcription, Genetic	2020
Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis. British journal of clinical pharmacology, 2021, Volume: 87, Issue:5 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Fibroblast Growth Factor-23; Humans; Hypophosphatemia; Maltose; Prospective Studies	2021
Parenteral iron therapy and phosphorus homeostasis: A review. American journal of hematology, 2021, 05-01, Volume: 96, Issue:5 Topics: Anemia, Hypochromic; Calcitriol; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Humans; Hypophosphatemia; Infusions, Parenteral; Iron; Iron Deficiencies; Kidney; Malabsorption Syndromes; Maltose; Osteomalacia; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary	2021
Intravenous iron induced severe hypophophatemia in a gastric bypass patient. Endocrinologia, diabetes y nutricion, 2019, Volume: 66, Issue:5 Topics: Female; Ferric Compounds; Gastric Bypass; Humans; Hypophosphatemia; Iron Deficiencies; Maltose; Middle Aged; Obesity, Morbid; Postoperative Complications	2019

Trials

5 trial(s) available for acebutolol and Hypophosphatemia

Article	Year
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. JAMA, 2020, 02-04, Volume: 323, Issue:5 Topics: Adult; Anemia, Iron-Deficiency; Biomarkers; Disaccharides; Female; Ferric Compounds; Headache; Hematinics; Humans; Hypophosphatemia; Incidence; Male; Maltose; Middle Aged; Nausea; Phosphates	2020
Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose-the randomized controlled HOMe aFers study. BMC medicine, 2020, 07-13, Volume: 18, Issue:1 Topics: Adult; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Fibroblast Growth Factor-23; Humans; Hypophosphatemia; Iron; Male; Maltose; Prospective Studies	2020
Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial. American journal of hematology, 2018, Volume: 93, Issue:5 Topics: Adult; Aged; Anemia, Iron-Deficiency; Drug Hypersensitivity; Female; Ferric Compounds; Ferrosoferric Oxide; Humans; Hypophosphatemia; Male; Maltose; Middle Aged; Treatment Outcome	2018
High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia. Journal of the American College of Cardiology, 2018, 05-15, Volume: 71, Issue:19 Topics: Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Ferric Compounds; Heart Failure; Humans; Hypophosphatemia; Infusions, Intravenous; Maltose; Pilot Projects; Prospective Studies; Stroke Volume	2018
Randomized trial of intravenous iron-induced hypophosphatemia. JCI insight, 2018, 12-06, Volume: 3, Issue:23 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Calcitriol; Calcium; Female; Ferric Compounds; Ferrosoferric Oxide; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Humans; Hyperparathyroidism; Hypophosphatemia; Iron; Male; Maltose; Middle Aged; Phosphates; Risk Factors	2018

Other Studies

29 other study(ies) available for acebutolol and Hypophosphatemia

Article	Year
Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose. The Journal of clinical endocrinology and metabolism, 2022, 03-24, Volume: 107, Issue:4 Topics: Alkaline Phosphatase; Anemia, Iron-Deficiency; Biomarkers; Calcium; Disaccharides; Familial Hypophosphatemic Rickets; Female; Ferric Compounds; Humans; Hypophosphatemia; Iron; Male; Maltose; Minerals; Osteomalacia; Parathyroid Hormone; Risk Factors	2022
Hypophosphatemic osteomalacia, a side effect of iron carboxymaltose administration. Revista espanola de enfermedades digestivas, 2022, Volume: 114, Issue:6 Topics: Ferric Compounds; Humans; Hypophosphatemia; Iron; Maltose; Osteomalacia	2022
High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment. Drug safety, 2022, Volume: 45, Issue:10 Topics: Disaccharides; Ferric Compounds; Hormones; Humans; Hypophosphatemia; Iron; Maltose; Phosphates; Prospective Studies; Risk Assessment	2022
Severe hypophosphatemia secondary to chronic treatment with endovenous ferric carboxymaltose. Endocrinologia, diabetes y nutricion, 2022, Volume: 69, Issue:8 Topics: Ferric Compounds; Humans; Hypophosphatemia; Maltose	2022
What is wrong in doing good? British journal of haematology, 2023, Volume: 202, Issue:6 Topics: Anemia, Iron-Deficiency; Ferric Compounds; Humans; Hypophosphatemia; Iron; Maltose	2023
Editorial: awareness and prevention of intravenous iron-induced hypophosphataemia. Alimentary pharmacology & therapeutics, 2019, Volume: 50, Issue:5 Topics: Disaccharides; Ferric Compounds; Humans; Hypophosphatemia; Incidence; Inflammatory Bowel Diseases; Iron; Maltose	2019
Editorial: awareness and prevention of intravenous iron-induced hypophosphataemia. Authors' reply. Alimentary pharmacology & therapeutics, 2019, Volume: 50, Issue:5 Topics: Disaccharides; Ferric Compounds; Humans; Hypophosphatemia; Incidence; Inflammatory Bowel Diseases; Iron; Maltose	2019
Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia. Rheumatology (Oxford, England), 2020, 08-01, Volume: 59, Issue:8 Topics: Adult; Anemia, Iron-Deficiency; Antibodies, Monoclonal, Humanized; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypophosphatemia; Male; Maltose; Osteomalacia; Treatment Outcome	2020
Hypophosphatemia in children treated with ferric carboxymaltose. Acta paediatrica (Oslo, Norway : 1992), 2020, Volume: 109, Issue:7 Topics: Anemia, Iron-Deficiency; Child; Ferric Compounds; Humans; Hypophosphatemia; Maltose	2020
Sharp rises in FGF23 and hypophosphatemia after intravenous iron administration do not cause myocardial damage. Clinical research in cardiology : official journal of the German Cardiac Society, 2020, Volume: 109, Issue:10 Topics: Biomarkers; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Heart Failure; Humans; Hypophosphatemia; Injections, Intravenous; Maltose; Stroke Volume	2020
High Risk of Hypophosphatemia in Patients with Previous Bariatric Surgery Receiving Ferric Carboxymaltose: A Prospective Cohort Study. Obesity surgery, 2020, Volume: 30, Issue:7 Topics: Adult; Aged; Anemia, Iron-Deficiency; Bariatric Surgery; Female; Ferric Compounds; Fibroblast Growth Factor-23; Humans; Hypophosphatemia; Maltose; Middle Aged; Obesity, Morbid; Prospective Studies; Young Adult	2020
Case report: A rare cause of severe hypophosphatemia. Annales d'endocrinologie, 2020, Volume: 81, Issue:2-3 Topics: Administration, Oral; Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Hypophosphatemia; Infusions, Intravenous; Maltose; Middle Aged; Phosphates; Severity of Illness Index; Vitamin D Deficiency	2020
Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status. BMC gastroenterology, 2020, Jun-10, Volume: 20, Issue:1 Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Humans; Hypophosphatemia; Incidence; Male; Maltose; Middle Aged; Nutritional Status; Phosphates; Prospective Studies; Risk Factors; Treatment Outcome; Vitamin D; Young Adult	2020
Ferric carboxymaltose (Ferinject®) associated hypophosphataemia: case report illustrating the need for increased awareness to minimise incidence and risk. Acute medicine, 2020, Volume: 19, Issue:2 Topics: Ferric Compounds; Humans; Hypophosphatemia; Incidence; Maltose	2020
Hypophosphatemia Is Common After Intravenous Ferric Carboxymaltose Infusion Among Patients With Symptomatic Heart Failure With Reduced Ejection Fraction. Journal of clinical pharmacology, 2021, Volume: 61, Issue:4 Topics: Adult; Aged; Creatinine; Female; Ferric Compounds; Heart Failure; Humans; Hypophosphatemia; Infusions, Intravenous; Iron Deficiencies; Male; Maltose; Middle Aged; Phosphates; Retrospective Studies; Stroke Volume; Time Factors	2021
Refractory hypophosphatemia following ferric carboxymaltose administration. CEN case reports, 2021, Volume: 10, Issue:4 Topics: Administration, Intravenous; Adult; Colitis, Ulcerative; Female; Ferric Compounds; Humans; Hypophosphatemia; Maltose; Phosphates	2021
Phosphorus levels in children treated with intravenous ferric carboxymaltose. American journal of hematology, 2021, 06-01, Volume: 96, Issue:6 Topics: Adolescent; Age Factors; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Humans; Hypophosphatemia; Infant; Infusions, Intravenous; Male; Maltose; Phosphorus; Retrospective Studies; Young Adult	2021
Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2021, Volume: 53, Issue:7 Topics: Administration, Intravenous; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferritins; Hemoglobins; Humans; Hypophosphatemia; Inflammatory Bowel Diseases; Iron; Male; Maltose; Phosphates; Prevalence; Risk Factors; Severity of Illness Index; Treatment Outcome	2021
Hypophosphataemia Following Ferric Carboxymaltose Infusion. Journal of paediatrics and child health, 2021, Volume: 57, Issue:9 Topics: Ferric Compounds; Humans; Hypophosphatemia; Maltose	2021
Blood and Bone Loser. Gastroenterology, 2017, Volume: 152, Issue:6 Topics: Administration, Intravenous; Anti-Inflammatory Agents; Biopsy; Crohn Disease; Digestive System Surgical Procedures; Drug Therapy, Combination; Femoral Neck Fractures; Ferric Compounds; Gastrointestinal Agents; Hematinics; Humans; Hypophosphatemia; Hypophosphatemia, Familial; Magnetic Resonance Imaging; Male; Maltose; Middle Aged; Osteomalacia; Postoperative Hemorrhage	2017
Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration. BMJ case reports, 2018, Jan-03, Volume: 2018 Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Crohn Disease; Diagnosis, Differential; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypophosphatemia; Male; Maltose; Middle Aged; Osteomalacia; Phosphates; Treatment Outcome	2018
Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside. Alimentary pharmacology & therapeutics, 2019, Volume: 50, Issue:4 Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Disaccharides; Female; Ferric Compounds; Humans; Hypophosphatemia; Incidence; Inflammatory Bowel Diseases; Male; Maltose; Middle Aged; Norway; Prospective Studies; Quality of Life; Risk Factors	2019
[Hypophosphatemia, a poorly known adverse reaction of intravenous use of iron]. Medicina clinica, 2014, Sep-15, Volume: 143, Issue:6 Topics: Aged; Anemia, Iron-Deficiency; Causality; Diabetes Mellitus, Type 2; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Hepatitis C, Chronic; Humans; Hypocalcemia; Hypophosphatemia; Infusions, Intravenous; Male; Maltose	2014
Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient. European journal of clinical nutrition, 2014, Volume: 68, Issue:4 Topics: Administration, Oral; Anemia, Iron-Deficiency; Anorexia; Bulimia; Dietary Supplements; Female; Ferric Compounds; Humans; Hypophosphatemia; Injections, Intravenous; Malnutrition; Maltose; Parenteral Nutrition; Phosphates; Weight Loss; Young Adult	2014
[Intravenous ferric carboxymaltose-associated hypophosphatemia in patients with iron deficiency anemia. A common side effect]. Medicina clinica, 2015, Aug-07, Volume: 145, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Hematinics; Humans; Hypophosphatemia; Infusions, Intravenous; Logistic Models; Male; Maltose; Middle Aged; Retrospective Studies; Treatment Outcome	2015
Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions. British journal of clinical pharmacology, 2017, Volume: 83, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disaccharides; Drug Hypersensitivity; Female; Ferric Compounds; Humans; Hypophosphatemia; Infusions, Intravenous; Male; Maltose; Middle Aged; Prevalence; Retrospective Studies; Young Adult	2017
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk. PloS one, 2016, Volume: 11, Issue:12 Topics: Administration, Intravenous; Adult; Aged; Anemia, Iron-Deficiency; Biomarkers; Disaccharides; Female; Ferric Compounds; Fibroblast Growth Factor-23; Humans; Hypophosphatemia; Male; Maltose; Middle Aged; Phosphates; Prevalence; Retrospective Studies; Risk	2016
Ferric carboxymaltose-induced hypophosphataemia after kidney transplantation. The Netherlands journal of medicine, 2017, Volume: 75, Issue:2 Topics: Adult; Aged; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypophosphatemia; Kidney Transplantation; Male; Maltose; Phosphates; Postoperative Complications	2017
Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient. Transplantation, 2010, Oct-15, Volume: 90, Issue:7 Topics: Adult; Female; Ferric Compounds; Glomerular Filtration Rate; Humans; Hypophosphatemia; Injections, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Maltose; Phosphates; Polycystic Kidney Diseases; Reference Values; Transplantation, Homologous	2010